Image

India Molecular Diagnostic Controls Market - Industry Trends and Forecast to 2031

Healthcare

Image

India Molecular Diagnostic Controls Market - Industry Trends and Forecast to 2031

  • Healthcare
  • Upcoming Report
  • Feb 2024
  • Country Level
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

India Molecular Diagnostic Controls Market, By Product (Independent Controls, Instrument Specific Controls), Analyte Type (Single Analyte Controls, Multi Analyte Controls), Application (Infectious Disease, Oncology, Genetic Testing, Others), End User (Clinical Laboratories, Hospitals, IVD Manufacturers & Contract Research Organizations, Academic & Research Institutes, Others), Distribution Channel (Retail Sales, Direct Tender) - Industry Trends and Forecast to 2031.

India Molecular Diagnostic Controls Market Analysis and Size

Molecular diagnostic controls are essential for quality assurance in laboratory testing. They serve as standardized samples with known concentrations of specific nucleic acids or other molecular targets. Laboratories use these controls to validate and monitor the performance of their molecular diagnostic assays. Molecular diagnostic controls help assess the accuracy and precision of test results. By using controls with known concentrations of target biomolecules, laboratories can verify that their testing methods provide reliable and consistent results. Adherence to regulatory standards is crucial in the field of diagnostics. Molecular diagnostic controls are often required by regulatory agencies to ensure that laboratories meet quality and accuracy standards. Compliance with regulations helps maintain the integrity of diagnostic testing.

Data Bridge Market Research analyzes that the India molecular diagnostic controls market, which was USD 46.14 Million in 2023, is likely to reach USD 128.87 million by 2031 and is expected to undergo a CAGR of 13.7% during the forecast period. “Clinical laboratories” dominate the end user segment of the molecular diagnostic controls market due to the growing prevalence of infectious diseases.

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

India Molecular Diagnostic Controls Market Scope and Segmentation

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Product (Independent Controls, Instrument Specific Controls), Analyte Type (Single Analyte Controls, Multi Analyte Controls), Application (Infectious Disease, Oncology, Genetic Testing, Others), End User (Clinical Laboratories, Hospitals, IVD Manufacturers & Contract Research Organizations, Academic & Research Institutes, Others), Distribution Channel (Retail Sales, Direct Tender)

Country Covered

India

Market Players Covered

Thermo Fisher Scientific Inc. (U.S.), ASURAGEN, INC.(U.S.), Merck KGaA (Germany), SERACARE LIFE SCIENCES (U.S.), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux SA (France), Abbott (U.S.), Microbiologics (U.S.)

Market Opportunities

  • Rising incidence of chronic diseases
  • Rise in the number of accredited clinical laboratories
  • Technological innovations in manufacturing

Market Definition

Molecular diagnostic controls are specific materials used in molecular diagnostic testing to ensure the accuracy, reliability, and precision of the results obtained from the testing process. Molecular diagnostics involves the analysis of genetic material, such as DNA or RNA, to detect and monitor various diseases, including genetic disorders, infectious diseases, and certain types of cancer.

India Molecular Diagnostic Controls Market Dynamics

Drivers

  • Rising Incidence of Diseases

The rising prevalence of infectious diseases, genetic disorders, and chronic conditions is driving the demand for accurate and reliable diagnostic tests. Molecular diagnostic controls play a crucial role in ensuring the precision and reliability of these tests, contributing to effective disease management.

  • Advancements in Molecular Diagnostics

Ongoing advancements in molecular diagnostic technologies, including polymerase chain reaction (PCR), nucleic acid sequencing, and other molecular techniques, are expanding the capabilities of diagnostic testing. The development of new assays often requires corresponding molecular diagnostic controls for validation and quality assurance.

Opportunity

  • Rapid Growth of Point-of-Care Testing

The growth of point-of-care testing, where diagnostic tests are conducted near the patient rather than in a centralized laboratory, is increasing the demand for reliable molecular diagnostic controls. These controls are crucial for maintaining the accuracy of tests performed outside traditional laboratory settings.

Restraint/Challenge

  • Stringent Regulatory Approval Processes

The regulatory approval processes for diagnostic controls can be lengthy and rigorous. Compliance with regulatory requirements is necessary for market entry, but it can pose a challenge in terms of time and resources. Delays in approvals may slow down the introduction of new molecular diagnostic controls to the market.

Recent Development

  • In June 2021, Bio-Rad Laboratories, Inc. announced that it has undergone partnership with Seegene, Inc. for the development and commercialization of infectious disease molecular diagnostic products. This partnership done by the company has increased its demand and sales in the market

India Molecular Diagnostic Controls Market Scope

The molecular diagnostic controls market is segmented on the basis of product, analyte type, application, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

  • Independent Controls
  • Instrument Specific Controls

Analyte Type

  • Single Analyte Controls
  • Multi Analyte Controls

Application

  • Infectious Disease
  • Oncology
  • Genetic Testing
  • Others

End User

  • Clinical Laboratories
  • Hospitals
  • IVD Manufacturers & Contract Research Organizations
  • Academic & Research Institutes
  • Others

Distribution Channel

  • Retail Sales
  • Direct Tender

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The molecular diagnostic controls market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the molecular diagnostic controls market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on global the Molecular diagnostic controls market.

Competitive Landscape and India Molecular Diagnostic Controls Market Share Analysis

The molecular diagnostic controls market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the molecular diagnostic controls market.

Some of the major players operating in the molecular diagnostic controls market are:

  • Thermo Fisher Scientific Inc. (U.S.)
  • ASURAGEN, INC.(U.S.)
  • Merck KGaA (Germany)
  • SERACARE LIFE SCIENCES (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • bioMérieux SA (France)
  • Abbott (U.S.)
  • Microbiologics (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The India Molecular Diagnostic Controls Market size will be worth USD 128.87 million by 2031 during the forecast period.
The India Molecular Diagnostic Controls Market growth rate is 13.7% during the forecast period.
The Rising Incidence of Diseases & Advances in Molecular Diagnostics are the growth drivers of the Molecular Diagnostic Controls Market.
The product, analyte type, application, end-user, and distribution channel are the factors on which the Molecular Diagnostic Controls Market research is based.
The major companies in the Molecular Diagnostic Controls Market are Thermo Fisher Scientific Inc. (U.S.), ASURAGEN, INC.(U.S.), Merck KGaA (Germany), SERACARE LIFE SCIENCES (U.S.), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux SA (France), Abbott (U.S.), Microbiologics (U.S.).
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials